Mölndal, Sweden

Christer Ralf Westerlund

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Inventor Profile: Christer Ralf Westerlund**

Introduction

Christer Ralf Westerlund is an esteemed inventor based in Mölndal, Sweden, recognized for his impactful contributions to the field of pharmaceutical sciences. With a total of three patents to his name, Westerlund's work primarily focuses on innovative therapeutic agents aimed at addressing various medical conditions.

Latest Patents

Westerlund's latest patents include a groundbreaking compound represented by Formula (I), which is particularly useful in the treatment or prevention of diseases mediated through glucokinase (GLK or GK). This innovative compound is designed to lead to a decreased glucose threshold for insulin secretion, which could significantly benefit patients with metabolic disorders. Another key patent discusses novel compounds of the formula (I) and their utility in modulating nuclear hormone receptors, specifically the Liver X Receptor (LXR) α (NR1H3) and/or β (NR1H2). These compounds can potentially treat and prevent various clinical conditions, including cardiovascular diseases such as atherosclerosis, inflammatory diseases, Alzheimer's disease, lipid disorders, insulin resistance, and type 2 diabetes, thus addressing the broader spectrum of the metabolic syndrome. Methods for their therapeutic use and pharmaceutical compositions containing these compounds have also been highlighted in this patent.

Career Highlights

Westerlund is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca involves developing innovative solutions for complex health conditions, illustrating his commitment to advancing medical science and improving patient outcomes.

Collaborations

Throughout his career, Westerlund has worked alongside notable colleagues such as Jonas Boström and Kay Brickmann. These collaborations have further enriched his research endeavors, fostering a dynamic environment for innovation and discovery within the pharmaceutical domain.

Conclusion

Christer Ralf Westerlund stands out as a prominent figure in the field of pharmaceutical innovation. His dedication to developing novel therapeutic agents underscores the critical role inventors play in advancing healthcare solutions. With several patents to his name, Westerlund’s future contributions are eagerly anticipated in the quest for effective treatments and improved patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…